Title :

Recurrent cardiac arrest due to eosinophilia-related coronary vasospasm successfully treated by benralizumab

Author(s) :

Groh, Matthieu [Auteur]
Hôpital Foch [Suresnes]
Pineton De Chambrun, Marc [Auteur]
Sorbonne Université [SU]
CHU Pitié-Salpêtrière [AP-HP]
Georges, Jean-Louis [Auteur]
Centre Hospitalier de Versailles André Mignot [CHV]
Panel, Kewin [Auteur]
Hôpital Foch [Suresnes]
Lefevre, Guillaume [Auteur]
Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286
Kahn, Jean-Emmannuel [Auteur]
Service de médecine interne [CHU Ambroise Paré]
Tcherakian, Colas [Auteur]
Hôpital Foch [Suresnes]
Convers-Domart, Raphaele [Auteur]
Centre Hospitalier de Versailles André Mignot [CHV]

Journal title :

The Journal of Allergy and Clinical Immunology: In Practice

Abbreviated title :

J Allergy Clin Immunol Pract

Publication date :

2021-05-18

ISSN :

2213-2201

HAL domain(s) :

Sciences du Vivant [q-bio]

English abstract : [en]

Eosinophilia-related coronary vasospasm is a diagnosis to consider in patients with chest pain and eosinophilia. Indefinite treatment aiming to normalize absolute eosinophil counts is warranted. In this setting, benralizumab ...
Show more >Eosinophilia-related coronary vasospasm is a diagnosis to consider in patients with chest pain and eosinophilia. Indefinite treatment aiming to normalize absolute eosinophil counts is warranted. In this setting, benralizumab is a promising steroid-free treatment regimen and deserves further investigation.Show less >

Language :

Anglais

Peer reviewed article :

Oui

Audience :

Internationale

Popular science :

Non

Administrative institution(s) :

CHU Lille
Inserm
Université de Lille

Collections :

• Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286

Submission date :

2021-07-06T12:44:18Z
2024-03-04T15:16:19Z